Strååt Klas, de Klark Rainier, Gredmark-Russ Sara, Eriksson Per, Söderberg-Nauclér Cecilia
Department of Medicine, Center forMolecular Medicine, Experimental Cardiovascular Research Unit, Karolinska Institutet, Stockholm, Sweden.
J Virol. 2009 Jan;83(2):830-5. doi: 10.1128/JVI.01363-08. Epub 2008 Oct 22.
Human cytomegalovirus (HCMV) has been suggested to contribute to the development of vascular diseases. Since matrix metalloproteinases (MMPs) have been implicated in atherosclerosis and plaque rupture, we investigated the effect of HCMV infection on MMP expression in human macrophages. We used quantitative real-time PCR, Western blotting, and gelatin zymography to study the expression and activity of MMP-2, -3, -7, -9, -12, -13, and -14 and of tissue inhibitor of metalloproteinase 1 (TIMP-1), -2, -3, and -4. HCMV infection reduced MMP-9 mRNA, protein, and activity levels but increased TIMP-1 mRNA and protein levels. Furthermore, a decrease in MMP-12, MMP-14, TIMP-2, and TIMP-3 mRNA levels could be detected. The MMP-9 and TIMP-1 mRNA alterations required viral replication. MMP-9 mRNA expression was affected by an immediate-early or early viral gene product, whereas TIMP-1 mRNA expression was affected by late viral gene products. We conclude that HCMV infection specifically alters the MMP-9/TIMP-1 balance in human macrophages, which in turn reduces MMP-9 activity in infected cells. Since MMP-9 prevents atherosclerotic plaque development in mice, these results suggest that HCMV may contribute to atherogenesis through specific effects on MMP-9 activity.
有人提出人类巨细胞病毒(HCMV)与血管疾病的发生有关。由于基质金属蛋白酶(MMPs)与动脉粥样硬化和斑块破裂有关,我们研究了HCMV感染对人巨噬细胞中MMP表达的影响。我们使用定量实时PCR、蛋白质印迹法和明胶酶谱法研究了MMP-2、-3、-7、-9、-12、-13和-14以及金属蛋白酶组织抑制剂1(TIMP-1)、-2、-3和-4的表达和活性。HCMV感染降低了MMP-9的mRNA、蛋白质和活性水平,但增加了TIMP-1的mRNA和蛋白质水平。此外,还可检测到MMP-12、MMP-14、TIMP-2和TIMP-3的mRNA水平下降。MMP-9和TIMP-1的mRNA改变需要病毒复制。MMP-9的mRNA表达受病毒即刻早期或早期基因产物的影响,而TIMP-1的mRNA表达受病毒晚期基因产物的影响。我们得出结论,HCMV感染特异性地改变了人类巨噬细胞中MMP-9/TIMP-1的平衡,进而降低了感染细胞中MMP-9的活性。由于MMP-9可预防小鼠动脉粥样硬化斑块的形成,这些结果表明HCMV可能通过对MMP-9活性的特异性作用促进动脉粥样硬化的发生。